Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

       
Поиск   
Главное меню
ДомойНовостиСтатьиПостановка звуковФайлыКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинКарта сайта

Поздравляем!
Поздравляем нового Логобуржца lanna2010 со вступлением в клуб!

Реклама

КНИЖНЫЙ МИР

Novel multi-target therapies for neurodegenerative diseases treatment   Lana Kupershmidt

Novel multi-target therapies for neurodegenerative diseases treatment

140 страниц. 2012 год.
LAP Lambert Academic Publishing
Due to the complex pathophysiology of neurodegenerative diseases, an innovative approach towards neuroprotection or neurorestoration may be the development of multifunctional pharmaceuticals. Such drugs target an array of pathological pathways, each of which is believed to contribute to the cascades that ultimately lead to neuronal cell death. To date, Professor Youdim and our research group are designing pluripotential non-toxic, brain-permeable iron-chelating drug candidates possessing diverse pharmacological properties that can act on multiple targets and pathological features ascribed to Parkinson's disease, Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The aim of my PhD thesis was to examine the potential therapeutic utility of these novel multi-target drugs in the treatment of AD, aged-related cognitive decline and ALS. This book discusses the multiple effects of these compounds, concerning their neuroprotective/neurorestorative molecular mechanisms in vivo...
 
- Генерация страницы: 0.05 секунд -